Medication info

Hyuniz Losartan Potassium Tablet 50 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Huons Meditech Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201502422 · Approved 2015.04.24

This product's status changed to Expired on 2025.04.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after the start of treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily, or increased to 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be used in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when coadministered with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient groups No initial dose adjustment is necessary for elderly patients aged 75 years or younger. For patients older than 75 years, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced intravascular effective blood volume (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents aged 6 years and older Patients weighing 20 kg or more and less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this medicine once daily; depending on the patient's blood pressure response, the dose may be increased to a maximum of 50mg once daily. Patients weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily; depending on the patient's blood pressure response, the dose may be increased to a maximum of 100 mg once daily. Children younger than 6 years: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
Huons Meditech Co., Ltd.

Efficacy & effects

Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used to lower blood pressure in patients with hypertension. Additionally, it helps treat kidney disease in hypertensive patients with type 2 diabetes. Therefore, it is effective in protecting kidney function in hypertensive and diabetic patients. This medication plays a crucial role in blood pressure control and slowing the progression of kidney disease. It will assist patients in improving blood pressure management and kidney health.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after the start of treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily, or increased to 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be used in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when coadministered with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient groups No initial dose adjustment is necessary for elderly patients aged 75 years or younger. For patients older than 75 years, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced intravascular effective blood volume (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents aged 6 years and older Patients weighing 20 kg or more and less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this medicine once daily; depending on the patient's blood pressure response, the dose may be increased to a maximum of 50mg once daily. Patients weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily; depending on the patient's blood pressure response, the dose may be increased to a maximum of 100 mg once daily. Children younger than 6 years: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. This medication should not be used in patients with severely impaired liver function, hereditary angioedema, or certain genetic lactose metabolism disorders. Particular caution is required when administering this medication to elderly patients, those with reduced kidney function, or patients with hyperkalemia, and regular monitoring of blood pressure and electrolyte levels in the blood is necessary. This drug may cause various side effects, including muscle cramps, dizziness, cough, and upper respiratory infections, and any unusual symptoms should be discussed with healthcare providers. Serious allergic reactions, such as angioedema, can occur rarely, so if symptoms such as swelling of the lips or face or difficulty breathing appear, immediate treatment should be sought. This medication may interact with other drugs, so inform healthcare providers if you are currently taking other medications before starting this drug. Women who are pregnant or breastfeeding are advised not to take this medication; if necessary, consult a professional before use. This medication should not be given to children, particularly those under 6 years old or with severely impaired kidney function. During treatment, blood pressure may drop suddenly, so if symptoms such as dizziness or loss of consciousness occur, notify healthcare providers immediately. Avoid taking potassium supplements or foods containing potassium indiscriminately while using this medication to prevent hyperkalemia. Store this medication safely out of reach of children, and do not transfer it to another container.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • lumbago
  • leg pain
  • dizziness
  • congestion
Show 119 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness/fatigue
  • edema/swelling
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm skin peeling
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina pectoris
  • second-degree AV block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • myotonia
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory disturbance
  • decreased libido
  • memory impairment
  • migraine
  • hypersensitivity
  • sensory abnormalities
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • pulmonary congestion
  • chest discomfort
  • alopecia
  • dermatitis
  • dry skin
  • petechial hemorrhage
  • erythema
  • flushing
  • photosensitivity reaction
  • pruritus
  • rash
  • sweating
  • urticaria
  • blurred vision
  • burning and pain in the eyes
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • decreased vision
  • erectile dysfunction
  • nocturia
  • polyuria
  • urinary tract infection
  • angioedema
  • vasculitis
  • anaphylaxis-like syndrome
  • abnormal liver function
  • hepatitis
  • malaise
  • thrombocytopenia
  • elevated creatine kinase
  • rhabdomyolysis
  • dry cough
  • erythema multiforme
  • hyponatremia
  • elevated ALT
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopy
  • arrhythmia
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air or moisture and should be kept at room temperature between 1 to 30 degrees Celsius. Proper storage will maintain the drug's effectiveness and prevent degradation.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.